Aragon clinches $25m in series B
This article was originally published in Clinica
Palo Alto, California-based surgical device developer Aragon Surgical has closed a $25m series B financing round led by Cay City Capital. Integral Capital Partners, as well as existing investors Delphi Ventures and ONSET Ventures, also participated in the fundraising. Aragon launched its first product, the LapCap pneumoperitoneum creation assist device, in September 2007 and said it has "several additional products in development".
You may also be interested in...
Amgen and Mylan will face US Food and Drug Administration actions dates on two of their biosimilar candidates in December, while ANDA sponsors have date-certain launches for two generic products.
With the European Commission "carefully assessing" the judgment of Europe's highest court that CBD is not a narcotic, HBW Insight speaks to an expert in cannabis law about what is likely to happen next.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.